These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported Terminated 2008-006765-82 Preventive therapy for multidrug-resistant tuberculosis: a multicentre clincal trial. 2014-01-29 due-trials
Reported results 2009-016697-32 PRotease-Inhibitors MOnotherapy Strategies as maintenance therapy in persons with fully suppressed HIV replication: results from an open-label randomized comparative trial (PRIMO Trial) 2014-10-27 due-trials
Completed, but no date Terminated 2009-016705-42 Pilot study on efficacy of a simplification strategy from DRV/r 600/100 mg BID to DRV/r 800/100mg QD + OBT in HIV-positive patients HAART-experienced with virological response. bad-data
Ongoing 2010-023245-30 Treatment with Peg-interferon alfa-2a and ribavirin in patients with hepatitis HCV-related, with or without HIV co-infection, and end stage renal disease on dialysis not-yet-due
Ongoing 2011-004038-33 Non-inferiority,randomized clinical trial to evaluate the efficacy and the safety of the use of fixed-dose combination efavirenz/tenofovir/emtricitabine (Atripla) administered in alternate days versu... not-yet-due
Completed, but no date Terminated 2011-004693-29 Pegylated interferon alfa-2a USE FOR CONTROLLING virological rebound after suspension of antiretroviral treatment IN PATIENTS WITH CHRONIC HIV INFECTION bad-data
Ongoing 2011-005270-35 HIV-infected pregnant women treated with HAART: registry of pharmacokinetic parameters of new and commonly used antiretrovirals not-yet-due
Ongoing 2014-003874-17 Antiretroviral Pre-exposure prophylaxis for natural conception (PrEP-C) in serodiscordant female partners of HIV-infected men in sustained virologic suppression not-yet-due
Ongoing 2020-001390-76 A phase 3, randomized, open-labeled, multi-center study comparing clinical efficacy and safety of intravenous sarilumab plus standard of care compared to standard of care, in the treatment of patients... not-yet-due
Ongoing 2020-001528-32 Adaptive Randomized trial for therapy of COrona virus disease 2019 at home with oral antivirals not-yet-due